LongCovid
This recent study showed that myricetin (3,5,7-trihydroxy-2-(3,4,5-tri hydroxyphenyl)-4-benzopyrone), a common flavonol extracted from many natural plants and Chinese herb medicines, is able to inhibit binding between the receptor binding domain (RBD) of the SARS-CoV-2 protein and angiotensin-converting enzyme 2 (ACE2), demonstrating its potential as a viral-entry facilitator blocker. Furthermore, myricetin could also significantly inhibit SASR-CoV-2 replication in Vero E6 cells.
New World Health Organization article. “At 12 years old, Jay should be out playing sports and enjoying school and friendships. Instead, 18 months after a bout of COVID-19 and 6…
The 2nd official peer-reviewed article generated by the Long COVID project has just been published by Viruses MDPI: The Stereotypic Response of the Pulmonary Vasculature to Respiratory Viral Infections: Findings…
Nature has just published an excellent new review on Long COVID. This article presents the primary challenges concerning biological knowledge gaps and efficient remedies, discussing also the corresponding…
Trying to find a solution to this challenge, researchers from KU Leuven, a research university in Belgium, have been working to develop evidence-based guidelines to help health professionals…